Please Wait
Applying Filters...
menu
    • menu
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    IKT-001PRO

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Inhibikase Announces $110M Placement For IkT-001Pro Trial
    Inhibikase Announces $110M Placement For IkT-001Pro Trial

    09 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//en/news-release/2024/10/09/2960616/0/en/Inhibikase-Therapeutics-Announces-Pricing-of-110-Million-Private-Placement-to-Advance-IkT-001Pro-an-Optimized-Prodrug-of-Imatinib-into-a-Late-Stage-Trial-in-Pulmonary-Arterial-Hype.html

    GLOBENEWSWIRE
    09 Oct 2024
    Share Share
    Inhibikase IkT-001Pro PAH Treatment Pre-IND Outcomes
    Inhibikase IkT-001Pro PAH Treatment Pre-IND Outcomes

    09 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/09/2878689/0/en/Inhibikase-Therapeutics-Announces-Final-Pre-IND-Meeting-Outcomes-for-IkT-001Pro-as-a-Treatment-for-Pulmonary-Arterial-Hypertension.html

    GLOBENEWSWIRE
    09 May 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.